HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gregory L. Kay Curtis A. Prejean, Jr Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kay, G. L. Articles by Prejean, C. A. Search for Related Content PubMed PubMed Citation Articles by Kay, G. L. Articles by Prejean, C. A., Jr Related Collections Related Article

Ann Thorac Surg 1995;60:1640-1651
© 1995 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Influence of Ejection Fraction on Hospital Mortality, Morbidity, and Costs for CABG Patients

The Heart Institute, Good Samaritan Hospital, Los Angeles, California

Background. Preoperative ejection fraction (EF) has been shown to adversely affect postoperative hospital mortality and morbidity for patients undergoing isolated coronary artery bypass grafting.

Methods. To investigate influence of EF on isolated coronary artery bypass grafting outcomes (overall hospital mortality, hospital cardiac mortality, hospital morbidity, and hospital costs), data were reviewed from 1,354 consecutive patients who underwent isolated coronary artery bypass grafting between January 1, 1990, and April 30, 1992, at a single nonprofit hospital. Overall hospital mortality was 4.06% (cardiac, 2.36%). Hospital morbidity was 14.25% (including mortality). Hospital costs (not charges) averaged $16,673 per patient. To explore the impact of preoperative EF, EF was stratified into regular intervals. Each interval was then compared with regard to hospital mortality, morbidity, and average costs. A new statistical tool, discharge analysis, was developed to analyze the cost data. This was necessary because previous efforts at cost analysis have used tools inappropriate for real world cost data.

Results. The statistical analysis showed that patients with EF of 0.40 or greater had the best outcomes (lowest mortality, morbidity, and cost). Once the EF is 0.40 or greater the EF does not carry further predictive value. At EF less than 0.40, patients with EF less than 0.30 have a poorer outcome than patients with EF of 0.30 to 0.39.

Conclusions. (1) Ejection fraction is a valid predictor of mortality, morbidity and resource utilization based on statistical analysis. (2) Patients can be broadly grouped as having EF greater than 0.40, less than 0.30, or from 0.30 to 0.39 with regard to clinical and cost outcomes. (3) Postoperative length of stay is not predicted by risk-adjusted EF. (4) A new tool, discharge analysis, is presented to facilitate cost analysis.

Related Article

Discussion
Ann. Thorac. Surg. 1995 60: 1651. [Extract] [Full Text]

This article has been cited by other articles:

				J. A. Carr, B. E. Haithcock, G. Paone, A. F. Bernabei, and N. A. Silverman Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction Ann. Thorac. Surg., November 1, 2002; 74(5): 1531 - 1536. [Abstract] [Full Text] [PDF]

				J. T. Cope, A. K. Kaza, C. C. Reade, K. S. Shockey, J. A. Kern, C. G. Tribble, and I. L. Kron A cost comparison of heart transplantation versus alternative operations for cardiomyopathy Ann. Thorac. Surg., October 1, 2001; 72(4): 1298 - 1305. [Abstract] [Full Text] [PDF]

				j. Cross The Economics of Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1999; 3(4): 227 - 230. [Abstract] [PDF]

				B. S. Cain, D. R. Meldrum, K. S. Joo, J.-F. Wang, X. Meng, J. C. Cleveland Jr., A. Banerjee, and A. H. Harken Human SERCA2a levels correlate inversely with age in senescent human myocardium J. Am. Coll. Cardiol., August 1, 1998; 32(2): 458 - 467. [Abstract] [Full Text] [PDF]

				V. A. Ferraris, S. P. Ferraris, and A. Singh Operative Outcome And Hospital Cost J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 593 - 603. [Abstract] [Full Text]